IP Library Granted Patent US 10,561,354
Granted Patent B2
US 10,561,354 · App. 16/460,943 · Granted Feb 18, 2020

Advanced analyte sensor calibration and error detection

Inventors: Sebastian Böhm (San Diego, CA); Daiting Rong (San Diego, CA); Peter C. Simpson (Cardiff, CA)
Assignee: DexCom, Inc.
A61B5/1495A61B5/1451A61B5/1473A61B5/1486A61B5/14503A61B5/14517A61B5/14532A61B5/7257A61B5/7267G01D18/00G01N27/026G01N27/3274G01N33/49H05K999/00H05K999/99A61B5/14546A61B2560/0276
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,561,354
App. No.
16/460,943
Granted
Feb 18, 2020
Kind
B2
Abstract

Systems and methods for processing sensor data and self-calibration are provided. In some embodiments, systems and methods are provided which are capable of calibrating a continuous analyte sensor based on an initial sensitivity, and then continuously performing self-calibration without using, or with reduced use of, reference measurements. In certain embodiments, a sensitivity of the analyte sensor is determined by applying an estimative algorithm that is a function of certain parameters. Also described herein are systems and methods for determining a property of an analyte sensor using a stimulus signal. The sensor property can be used to compensate sensor data for sensitivity drift, or determine another property associated with the sensor, such as temperature, sensor membrane damage, moisture ingress in sensor electronics, and scaling factors.

Claims (7)

1. A method of calibrating at least one sensor data point from a transcutaneous glucose sensor, the method comprising:

using a calibration code associated with the transcutaneous glucose sensor, wherein the calibration code is based at least in part on a priori information obtained by performing measurements of at least one sensor characteristic of the transcutaneous glucose sensor during or after manufacturing the transcutaneous glucose sensor but before implantation of the transcutaneous glucose sensor in a host at the initiation of a sensor session, wherein the measured at least one sensor characteristic is associated with a thickness of a membrane system disposed on the transcutaneous glucose sensor, wherein the membrane system comprises an enzyme, wherein the a priori information accounts for a sensor sensitivity characteristic determined or assigned to the transcutaneous glucose sensor;

receiving the at least one sensor data point from the transcutaneous glucose sensor;

receiving one or more real-time inputs that influence calibration of the transcutaneous glucose sensor;

converting, in real-time, at least one sensor data point to an estimated glucose value, based at least in part on the calibration code and the real-time inputs.

2. The method of claim 1 , wherein the transcutaneous glucose sensor is formed as a wire.

3. The method of claim 1 , wherein at least one of the one or more real-time inputs comprises temperature.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 3, 2019
From: BOHM, SEBASTIAN; RONG, DAITING; SIMPSON, PETER C.
To: DEXCOM, INC.
Reel/Frame 049664/0179 →
Continuity (7)
Continuation 16405887 · May 7, 2019
Continuation 15994905 · May 31, 2018
Continuation 14860392 · Sep 21, 2015
Continuation 13446977 · Apr 13, 2012
Continuation 13446848 · Apr 13, 2012
Provisional Application 61476145 · Apr 15, 2011
Related Publication 20190320949A1 · Oct 24, 2019
Cited By (3)
US 12,318,200 US 12,343,143 US 12,666,543